Buscar resultados de ensayos clínicos
Hemophilia - 101 Studies Found
| Estado | Estudiar |
| Completed |
Nombre del estudio: Musculoskeletal Function in Hemophilia Condición: Hemophilia Fecha: 2006-05-09 |
| Completed |
Nombre del estudio: Study Evaluating Safety And Efficacy Of Moroctocog Alfa (AF-CC) In Previously Treated Hemophilia A Patients Condición: Hemophilia A Fecha: 2009-06-04 Intervenciones:
|
| Completed |
Nombre del estudio: Quality of Life in Adult Patients With Severe Haemophilia in Turkey Condición: Haemophilia Fecha: 2012-06-17 |
| Completed |
Nombre del estudio: Multicentre, Non-controlled, Prospective, Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemophilia A Condición: Haemophilia A Fecha: 2013-03-13 Intervenciones: Biological: Optivate 500IU |
| Completed |
Nombre del estudio: Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A Condición: Hemophilia A Fecha: 2005-08-30 Intervenciones:
|
| Completed |
Nombre del estudio: Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment Condición: Hemophilia A Fecha: 2008-02-04 Intervenciones:
|
| Completed |
Nombre del estudio: Phase I/IIa Study of FIXFc in Hemophilia B Patients Condición: Hemophilia B Fecha: 2008-07-14 Intervenciones: Drug: rFIXFc As specified in the treatment arm Other |
| Active, not recruiting |
Nombre del estudio: A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A Condición: Hemophilia A Fecha: 2012-03-28 Intervenciones: Biological: BAY94-9027 Intravenous infusion of BAY94-9027 |
| Completed |
Nombre del estudio: Canadian Hemophilia Prophylaxis Study Condición: Severe Hemophilia A Fecha: 2010-03-01 Intervenciones:
|
| Completed |
Nombre del estudio: Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A." Condición: Hemophilia A Fecha: 2015-10-20 Intervenciones:
|